CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders.
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reach the brain.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 14, 2020 | Series C | €10.50M | 1 |
European Innovation Council
|
— | Detail |
| Sep 14, 2020 | Grant | €2M | 1 |
European Innovation Council
|
— | Detail |
| Dec 12, 2018 | Series B | €9M | 4 | — | — | Detail |
| Oct 12, 2016 | Grant | €5.70M | — | — | — | Detail |
| Apr 13, 2015 | Series A | €2.10M | — | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
European Innovation Council
|
Yes | Series C |
Groupe Arnault
|
— | Series B |
Panakes Partners
|
— | Series B |
Sham Innovation Santé
|
— | Series B |
Supernova Invest
|
— | Series B |
AGORANOV
|
— | Seed |